Private Investments V. Lp OrbiMed is Director at ProNAi Therapeutics Inc (DNAI). They have made 1 open-market trade across 1 company since 2015, most recently 2015-07-21.
CIK 0001589316
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNAI | 1,814,949 | $2.8M |
Shares reported on the most recent Form 4, priced at the 2015-07-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNAI | BUY | 2015-07-21 | 2015-07-21 | $17.00 | $3.0M | -27.9% | -8.5% | -8.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.